BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
mangalam drug & chem ltd stock

MANGALAM DRUG & CHEM LTD Share Price

117.08 -0.33 (-0.28%)
Dec 13 2024 03:12 PM Pharmaceuticals NSE: MANGALAM

MANGALAM DRUG & CHEM LTD Share Price Update

As of the latest trading session, MANGALAM DRUG & CHEM LTD share price is currently at 117.08, which is down by -0.33 from its previous closing. Today, the stock has fluctuated between 114.51 and 117.90. Over the past year, MANGALAM DRUG & CHEM LTD has achieved a return of 18.83 %. In the last month alone, the return has been 10.13 %. Read More...

MANGALAM DRUG & CHEM LTD Performance

Day Range

Low114.51 High117.90
117.18

52 Week Range

Low 90.80 High 144.99
117.18

MANGALAM DRUG & CHEM LTD Share Price

11817

532637

MANGALAM

img img img img
No Data Available

Open Price

116.30

Prev. Close

117.41

Volume (Shares)

18246.00

Total traded value

21.38

Upper Circuit

140.89

Lower Circuit

93.92

Note: The current prices & values are delayed, Login to your account for live updates.

MANGALAM DRUG & CHEM LTD Fundamentals


(Standalone)

Market Cap (Cr) 185.31
PE Ratio (TTM) 19.79
Book Value / Share 93.14
Beta 0.78
ROE -6.15%
EPS (TTM) 5.95
Dividend Yield 0.00%
Net Profit Qtr (Cr) 2.69

MANGALAM DRUG & CHEM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 79.75
Operating Expense 78.89
Net Profit 2.69
Net Profit Margin (%) 3.37
Earnings Per Share (EPS) 1.70
EBITDA 8.84
Effective Tax Rate (%) -124.16
Particulars JUN 2024 (Values in Cr)
Revenue 76.49
Operating Expense 75.97
Net Profit 2.68
Net Profit Margin (%) 3.50
Earnings Per Share (EPS) 1.70
EBITDA 8.20
Effective Tax Rate (%) -362.06
Particulars MAR 2024 (Values in Cr)
Revenue 101.94
Operating Expense 98.34
Net Profit 3.55
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 2.24
EBITDA 11.75
Effective Tax Rate (%) 9.89
Particulars DEC 2023 (Values in Cr)
Revenue 97.05
Operating Expense 97.29
Net Profit 0.50
Net Profit Margin (%) 0.51
Earnings Per Share (EPS) 0.32
EBITDA 6.97
Effective Tax Rate (%) -1150.00
Particulars SEP 2023 (Values in Cr)
Revenue 81.37
Operating Expense 86.33
Net Profit -3.56
Net Profit Margin (%) -4.37
Earnings Per Share (EPS) -2.25
EBITDA 2.22
Effective Tax Rate (%) 25.05
Particulars MAR 2024 (Values in Cr)
Revenue 367.35
Operating Expense 379.75
Net Profit -9.05
Net Profit Margin (%) -2.46
Earnings Per Share (EPS) -5.72
EBITDA 17.49
Effective Tax Rate (%) 18.17
Particulars MAR 2023 (Values in Cr)
Revenue 370.20
Operating Expense 370.47
Net Profit 1.27
Net Profit Margin (%) 0.34
Earnings Per Share (EPS) 0.80
EBITDA 26.16
Effective Tax Rate (%) 42.53
Particulars MAR 2022 (Values in Cr)
Revenue 450.86
Operating Expense 423.42
Net Profit 19.66
Net Profit Margin (%) 4.36
Earnings Per Share (EPS) 12.42
EBITDA 49.14
Effective Tax Rate (%) 29.13
Particulars MAR 2021 (Values in Cr)
Revenue 379.98
Operating Expense 345.18
Net Profit 27.97
Net Profit Margin (%) 7.36
Earnings Per Share (EPS) 17.67
EBITDA 58.03
Effective Tax Rate (%) 29.22
Particulars MAR 2020 (Values in Cr)
Revenue 282.35
Operating Expense 277.28
Net Profit 8.25
Net Profit Margin (%) 2.92
Earnings Per Share (EPS) 5.21
EBITDA 24.86
Effective Tax Rate (%) -32.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.79
ROE % -6.68
ROCE % 1.16
Total Debt to Total Equity 0.78
EBITDA Margin 4.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 89.93
ROE % -6.15
ROCE % 1.16
Total Debt to Total Equity 0.66
EBITDA Margin 4.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 96.00
ROE % 0.84
ROCE % 6.25
Total Debt to Total Equity 0.58
EBITDA Margin 7.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 95.12
ROE % 13.98
ROCE % 17.57
Total Debt to Total Equity 0.56
EBITDA Margin 10.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 82.63
ROE % 23.83
ROCE % 27.41
Total Debt to Total Equity 0.52
EBITDA Margin 15.27
Particulars MAR 2020 (Values in Cr)
Book Value / Share 65.67
ROE % 8.27
ROCE % 10.51
Total Debt to Total Equity 0.59
EBITDA Margin 7.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.18
Total Assets 333.70
Total Liabilities 333.70
Total Equity 135.79
Share Outstanding 15828248
Price to Book Ratio 1.03
Return on Assets (%) -2.71
Return on Capital (%) -4.05
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.00
Total Assets 357.14
Total Liabilities 357.14
Total Equity 142.34
Share Outstanding 15828248
Price to Book Ratio 1.03
Return on Assets (%) -2.53
Return on Capital (%) -3.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.04
Total Assets 357.98
Total Liabilities 357.98
Total Equity 151.95
Share Outstanding 15828248
Price to Book Ratio 1.02
Return on Assets (%) 0.35
Return on Capital (%) 0.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.95
Total Assets 328.42
Total Liabilities 328.42
Total Equity 150.56
Share Outstanding 15828248
Price to Book Ratio 1.08
Return on Assets (%) 5.98
Return on Capital (%) 8.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 264.10
Total Liabilities 264.10
Total Equity 130.78
Share Outstanding 15828248
Price to Book Ratio 1.20
Return on Assets (%) 10.59
Return on Capital (%) 14.81
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.62
Total Assets 230.66
Total Liabilities 230.66
Total Equity 103.93
Share Outstanding 15828248
Price to Book Ratio 0.46
Return on Assets (%) 3.57
Return on Capital (%) 5.5
Particulars MAR 2024 (Values in Cr)
Net Income 3.97
Cash from Operations 4.00
Cash from Investing -11.82
Cash from Financing 5.22
Net change in Cash -2.68
Free Cash Flow 15.83
Particulars MAR 2024 (Values in Cr)
Net Income -11.05
Cash from Operations 12.35
Cash from Investing -17.90
Cash from Financing 5.69
Net change in Cash -0.03
Free Cash Flow 30.27
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 38.05
Cash from Investing -22.17
Cash from Financing -16.82
Net change in Cash -0.91
Free Cash Flow 65.97
Particulars MAR 2022 (Values in Cr)
Net Income 27.73
Cash from Operations 34.51
Cash from Investing -27.32
Cash from Financing 2.97
Net change in Cash 1.36
Free Cash Flow 62.18
Particulars MAR 2021 (Values in Cr)
Net Income 39.51
Cash from Operations 36.81
Cash from Investing -31.28
Cash from Financing 2.69
Net change in Cash -1.03
Free Cash Flow 68.25
Particulars MAR 2020 (Values in Cr)
Net Income 6.25
Cash from Operations 30.60
Cash from Investing -6.87
Cash from Financing -23.47
Net change in Cash 0.19
Free Cash Flow 37.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 37.68 3.57 502.48 37.54 / 77.70
BLISS GVS PHARMA LTD 173.80 21.75 1.81 1830.67 92.25 / 175.80
CIPLA LTD 1446.35 25.30 4.11 116809.04 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.80 141.25 4.12 1197.25 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 57.02 11.14 502.48 37.54 / 77.70
AMRUTAJAN HEALTH LTD 751.60 45.72 7.29 2172.92 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6636.00 128.88 24.42 16590.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 173.80 22.66 1.78 1830.67 92.25 / 175.80

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 118.60
  • 26 Days 114.20
  • 10 Days 117.60
  • 50 Days 115.80
  • 12 Days 117.00
  • 100 Days 115.40
  • 20 Days 114.70
  • 200 Days 122.80
117.14
PIVOT
First Resistance 118.97
Second Resistance 120.53
Third Resistance 122.36
First Support 115.58
Second Support 113.75
Third Support 112.19
RSI 55.27
MACD 2.75
Commodity Channel Index (CCI) 36.47
ADX 40.71
Williams % R -46.59

Over 1 Month

down

10.13

Over 3 Months

down

-8.55

Over 6 Months

down

9.77

Over 1 Year

down

18.83

Over 3 Years

down

-1.89

Over 5 Years

down

33.63

MANGALAM DRUG & CHEM LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MANGALAM DRUG & CHEM LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
39.32
Promoter Holdings
50.3
FII
0.11
DII
0.0
Promoter Shares(Pledge Percentage)
10.26
Name Category Shares Shares%
Shri Jb Pharma Private Limited Shareholding of Promoter and Promoter Group 2650000.0 16.74
Shree Kishoriju Trading & Investment Private Limited Shareholding of Promoter and Promoter Group 1098515.0 6.94
Shree Rasbihari Trading & Investment Private Limited Shareholding of Promoter and Promoter Group 1011663.0 6.39
Dhoot Goverdhan Murlidhar Shareholding of Promoter and Promoter Group 511792.0 3.23
Dhoot Brijmohan Murlidhar Shareholding of Promoter and Promoter Group 486996.0 3.08
Shweta Goverdhan Dhoot Shareholding of Promoter and Promoter Group 410000.0 2.59
Ashutosh Taparia Public Shareholding 302000.0 1.91
Smita A. Dhoot Shareholding of Promoter and Promoter Group 292500.0 1.85
Radhika A Dhoot Shareholding of Promoter and Promoter Group 292500.0 1.85
Rajkumari R. Dhoot Shareholding of Promoter and Promoter Group 275948.0 1.74
Jyotiprasad Taparia Public Shareholding 211291.0 1.33
Raj Exports Private Limited Shareholding of Promoter and Promoter Group 191520.0 1.21
Ambika Food Industries Private Limited Public Shareholding 164994.0 1.04
Govardhan Murlidhar Dhoot Shareholding of Promoter and Promoter Group 155330.0 0.98
Dhoot Rekha Goverdhan Shareholding of Promoter and Promoter Group 146760.0 0.93
Ajay R Dhoot Shareholding of Promoter and Promoter Group 138687.0 0.88
Dhoot Jyoti Brijmohan Shareholding of Promoter and Promoter Group 104550.0 0.66
Aditya R. Dhoot Shareholding of Promoter and Promoter Group 89225.0 0.56
Brijmohan Murlidhar Dhoot Shareholding of Promoter and Promoter Group 77473.0 0.49
Rajkamal Sukhani Shareholding of Promoter and Promoter Group 28520.0 0.18
Chandrakanta Murlidhar Dhoot Shareholding of Promoter and Promoter Group 67.0 0.0

MANGALAM DRUG & CHEM LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2017-12-21 0.5 Interim 2017-12-22 Equity shares 2005-08-30 0.0 Final 2005-09-01 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MANGALAM DRUG & CHEM LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MANGALAM DRUG & CHEM LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Mangalam Drugs and Organics Ltd?

Answer Field

The share price of Mangalam Drugs and Organics Ltd for NSE is ₹ 117.08 and for BSE is ₹ 117.

What is the Market Cap of Mangalam Drugs and Organics Ltd?

Answer Field

The market cap of Mangalam Drugs and Organics Ltd for NSE is ₹ 1,85.31 Cr. and for BSE is ₹ 1,85.19 Cr. as of now.

What is the 52 Week High and Low of Mangalam Drugs and Organics Ltd?

Answer Field

The 52 Week High and Low of Mangalam Drugs and Organics Ltd for NSE is ₹ 144.99 and ₹ 90.80 and for BSE is ₹ 144.65 and ₹ 85.16.

How to Buy Mangalam Drugs and Organics Ltd share?

Answer Field

You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mangalam Drugs and Organics Ltd?

Answer Field

The 1 year returns on the stock has been 18.83%.

What is the Current Share Price of Mangalam Drugs and Organics Ltd?

Answer Field

Mangalam Drugs and Organics Ltd share price is for NSE ₹ 117.08 & for BSE ₹ 117 as on Dec 13 2024 03:12 PM.

What is the Market Cap of Mangalam Drugs and Organics Ltd Share?

Answer Field

The market cap of Mangalam Drugs and Organics Ltd for NSE ₹ 1,85.31 & for BSE ₹ 1,85.19 as on Dec 13 2024 03:12 PM.

What is the P/E Ratio of Mangalam Drugs and Organics Ltd Share?

Answer Field

As on Dec 13 2024 03:12 PM the price-to-earnings (PE) ratio for Mangalam Drugs and Organics Ltd share is 19.79.

What is the PB ratio of Mangalam Drugs and Organics Ltd Share?

Answer Field

As on Dec 13 2024 03:12 PM, the price-to-book (PB) ratio for Mangalam Drugs and Organics Ltd share is 93.14.

How to Buy Mangalam Drugs and Organics Ltd Share?

Answer Field

You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mangalam Drugs and Organics Ltd Share on Bajaj Broking App?

Answer Field

To buy Mangalam Drugs and Organics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mangalam Drugs and Organics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader